The study also indicated that the ERK/NF-κB pathway may be a potential therapeutic target in arterial thrombosis and ALR-S could have a positive role in arterial thrombosis and related cardiovascular diseases. This evidence concerns the gene NFKB1 and Arterial thrombosis.